MET expression and amplification in patients with localized gastric cancer. - Wikidata - wikimedia - TriplyDB

MET expression and amplification in patients with localized gastric cancer.

MET expression and amplification in patients with localized gastric cancer.

http://www.wikidata.org/entity/Q36949256

about

Gastric biomarkers: a global review Recent updates of precision therapy for gastric cancer: Towards optimal tailored management Biomarker development in MET-targeted therapy Changing strategies for target therapy in gastric cancer Clinical significance of MET in gastric cancer Second-line treatment of metastatic gastric cancer: Current options and future directions Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis Gastric Cancer: New Drugs - New Strategies Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development.Targeting MET Amplification as a New Oncogenic Driver.Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization.Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation.MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met.Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.Targeted therapy in gastroesophageal cancers: past, present and future.Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue MET amplification as a potential therapeutic target in gastric cancer.Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors.Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review).Gastric cancer-molecular and clinical dimensions.Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target.MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Genomic dysregulation in gastric tumors.Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?Recent advances and future trends in the targeted therapy of metastatic gastric cancer.How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.Clinical management of advanced gastric cancer: the role of new molecular drugs.Role of c-mesenchymal-epithelial transition pathway in gastric cancer.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor.MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy.Advances of Molecular Targeted Therapy in Gastric Cancer.

P2860

Q26741859-2C2019F9-B136-4DDF-8FE1-97B8C45AF103 Q26746246-6E4D649C-A90E-439C-AFBB-83C46CC95065 Q26751332-17C46E72-9236-4AD8-9BB8-F2AE500795F2 Q26774513-E1913E16-FC01-4DAC-98D6-78A69576AB80 Q26776190-CB87A403-A96A-4E5E-A51E-AC922272998C Q26778027-C9E223E9-3F07-4FE6-92BA-3895DC8D5E5F Q27027981-84A7F09B-62A2-4727-86B4-9B8915D3A57F Q27028079-74A0EC6D-686C-4FD9-8ED0-E2C19F7E77C6 Q27320322-74DAA64A-3B78-4204-887D-5E71ABBB5A8D Q33917507-A43E8332-7FAA-4EB5-AFCA-47351EFE7D64 Q34309927-881D7F7B-BA63-4041-8599-90CF88A7CEC9 Q34445648-189340A0-BCFC-4A94-89FC-1FF648813336 Q34446136-4C98AC48-FB53-480E-9803-87AD619BF5A9 Q35159562-42EEF6BC-2D0D-452B-896B-CAE028BD4CAD Q35666332-A46D5DB8-5518-4298-81C0-D5AA52C45F20 Q35677873-BB1E83BB-C1FA-455D-8257-8DB6747429B4 Q35713396-6673F70B-DA22-4496-A02E-D75BCE115CA0 Q35719104-EE23373D-4C91-4980-A68A-968B408DA9A6 Q36089948-B5547A5A-4550-41BB-95C0-78F5F5883908 Q36294579-F9EE1482-F68A-4859-A573-7219CDBD3BE7 Q36413660-6E5C927E-D0BE-4DFF-956E-37A553F1AA2E Q36443572-F08BDD3E-6F31-484F-A50B-92006D195E2F Q36984821-B5B4CE1D-08E1-40D2-A0B5-0D8AB2823DBC Q37283371-DE5BAB4E-55B2-4556-AEB7-8059B0E2BDEE Q37342442-BFEB5466-AC92-4813-8C42-5D746FACEA08 Q37567784-94AC7D02-5171-4DDD-8232-74D30BC73629 Q37591176-FD48D801-6B5D-47CE-A7DB-7207AA72D494 Q37610073-99F96135-9888-4FAC-A9AB-E207D0666C9E Q37705824-A763D494-AE53-4E96-9FBE-5ACC22CD0646 Q38050092-F88CEE56-11EA-4D0D-8081-575A74C9C7EA Q38074157-0C68EB13-1C40-483B-B1B1-BC80799EC942 Q38184380-1140D117-D0C3-40E2-BFFA-7D95A10E2FDF Q38199128-6AEE6B46-1F01-42E0-9AA8-2838655AF5BB Q38241766-EED62177-4323-4822-886E-C071C79D5E1F Q38263841-0F10E25B-DF14-4CA3-BBFF-893F58BB3B7F Q38424220-7BDF40D9-EE9D-402A-A909-5C1D2B800605 Q38527414-4F9084F4-38F7-4638-86C6-7E6B4D8D3FB3 Q38661997-C0B38EE4-AF8D-4D62-B2C4-12D4E7E70CB7 Q38675350-71A7A35C-BF29-47A5-AF01-4E5A8D8481EC Q38732700-6D339A9E-C1FD-46B5-A5A9-5123BC4CB46D

P2860

MET expression and amplification in patients with localized gastric cancer.

http://www.wikidata.org/entity/Q36949256

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

MET expression and amplification in patients with localized gastric cancer.

@en

type

label

MET expression and amplification in patients with localized gastric cancer.

@en

prefLabel

MET expression and amplification in patients with localized gastric cancer.

@en

P1433

Q36949256-DBF28995-6208-416C-AAB1-2C6841A3F50D

P1476

Q36949256-59E71708-F4EB-42B5-9F86-9DAEA7C94F7A

P2093

Q36949256-24C6DBC0-5496-47E0-9FE3-6464568BDA51

Q36949256-2B217284-8819-4580-ADA0-28D28AC647AF

Q36949256-4B533687-7B4B-47B1-BFB2-B5A97E03949C

Q36949256-562822F8-C88B-475F-8444-CF7373BF6C1E

Q36949256-E5BAC10C-5CE5-4987-9451-7C67562262D9

Q36949256-E98A6475-B8CE-4DA1-B492-9A1C53C6844E

Q36949256-EF19D10C-47CB-4CB8-86F2-5CB7A87C6B73

Q36949256-F2C7F734-AF0E-4D89-AED4-876ADE85C051

P2860

Q36949256-0188DD5B-EE2E-4923-9694-0DAB8A359407

Q36949256-066BA259-09D8-4E09-83EE-F7C87F500B86

Q36949256-154F3F3D-F4B7-49B6-A22D-591E345B6E2E

Q36949256-159C90A0-D55A-488F-849C-33A3C99F0BCB

Q36949256-19C7E8E7-F8FA-4CEE-B523-344CD6D728E4

Q36949256-1CFC1848-9164-4931-A200-974C2EB8A65A

Q36949256-22274956-73AD-4784-9B31-04EB8E4CD5B6

Q36949256-22D3A589-F4A7-4BEB-8DF3-27EADC78A398

Q36949256-2CD57194-D840-49F3-82BA-A1E2684FCB9E

Q36949256-31AA31A8-608D-4B25-84C5-7BECE8E6B748

P304

Q36949256-6583D9B2-4F70-4938-B916-2D2D0822AC7A

P31

Q36949256-7DE7FE24-8E3B-4255-902C-6D8581896F2B

P356

Q36949256-3990C8A8-16BB-425B-B9B7-D4B8F0039140

P433

Q36949256-A82F9F19-F136-426F-9DB5-E6446FCAFCAB

P478

Q36949256-61E7BFBA-51A3-4B61-B9B1-4CBDA3ABB929

P577

Q36949256-57A23C9C-A062-4D9C-8625-8561ADE55437

P698

Q36949256-7D26961C-ACB6-4314-BCCA-C1D24179FD98

P932

Q36949256-D87A46F4-04D9-42AB-BFD8-F4B66E71DFD2

P356

1055-9965.EPI-10-1080

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

MET expression and amplification in patients with localized gastric cancer.

@en

P2093

Daniel G Coit

http://www.w3.org/2001/XMLSchema#string

David P Kelsen

http://www.w3.org/2001/XMLSchema#string

Laura H Tang

http://www.w3.org/2001/XMLSchema#string

Manish A Shah

http://www.w3.org/2001/XMLSchema#string

Martin R Weiser

http://www.w3.org/2001/XMLSchema#string

Suresh C Jhanwar

http://www.w3.org/2001/XMLSchema#string

Todd D Francone

http://www.w3.org/2001/XMLSchema#string

Yelena Y Janjigian

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

Met, metastasis, motility and more

Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23

Localization of the 5’ end of the MCF2 oncogene to human chromosome 15ql5→q23

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer.

Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians.

P304

1021-1027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-10-1080

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21393565

http://www.w3.org/2001/XMLSchema#string

P932

3690490

http://www.w3.org/2001/XMLSchema#string